Literature DB >> 24353550

Triple synchronous malignant tumors of colon, appendix and liver: A case report with literature review.

Shen Guoliang1, Huang Dongsheng2.   

Abstract

Synchronous cancers are defined as malignant tumors that occur simultaneously. Each tumor must be primary which eliminate the possibility of being metastatic lesion of the other. If three separate organs are involved, that is so-called triple synchronous malignancy with very low morbidity. We report a case of a 33 year old male patient with triple synchronous malignancies at the colon, appendix and liver.

Entities:  

Keywords:  Synchronous Malignancy

Year:  2013        PMID: 24353550      PMCID: PMC3809168          DOI: 10.12669/pjms.291.2277

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


Case Reports

A 33-year-old man was referred to our hospital with upper abdominal pain and poor appetite for two months; he claimed weight loss of 10 Kg. Medical history revealed no particular past history or familial history except chronic virus hepatitis B infection for 10 years. The fecal occult blood test was positive and serum AFP level was elevated (382280ng/ml). Enhanced abdomen CT scan demostrated a mass of 10cmx8cm in the left lobe of liver with portal vein cancerous embolus and a mass in the right colon with partial incomplete obstruction (Fig.1). Colonoscopy showed a mass in the right colon (65cm to anus). Pathological result confirmed it was adenocarcinoma.
Fig.1

: A left liver mass (10cmx8cm) with portal vein cancerous embolus and a right colon mass (3cmx3cm) with incomplete colon obstruction

A right colectomy was performed. The liver mass was unresectable due to infiltration to the porta hepatis. Postoperative pathological result showed highly-differentiated adenocarcinoma of right colon, partial myxoadenocarcinoma, carcinoid of appendix and hepatocellular carcinoma of left liver. Recovery after operation was uneventful and the patient was discharged 10 days after surgery. The patient underwent two times of TACE after operation and died of liver failure 8 months later since his diagnoses.

Discussion

Triple synchronous malignancies are relatively rare and it accounts for about 1.8%-3.9% of all primary tumors reported in the literature.[1],[2] According to the Warren’s criteria, such tumours occurring at different locations must be histologically malignant and separated by normal mucosa. Each tumour must not be a metastasis of another.[3] Meortal proposed that two primary tumors found within 6 months could be defined as synchronous, otherwise (more than 6 months) is metachronous. In our case, the three tumors were synchronous with different sites of liver, colon and appendix confirmed by postoperative pathological exam. Surgical statistics of synchronous and metachronous primary triple tumors *35 cases in total in the Table-I, 2 of 37 cases were excluded due to non availability of clinical details Literature review of past 20 years showed that there were 37 cases of triple primary tumors which have been reported so far. Those cases were mainly elderly males (94.1%),[4]-[8] with an average age of 70.1 years, Among the 37 cases reported, 19 cases were synchronous (51.4%), and there was no particular history except that one patient had atomic bomb exposure[9], one had bone marrow transplantation and two had silicosis diseases.[10],[11] Even though they were triple primary tumors, most cases had non-specific symptoms such as weight loss and anorexia. More than 90% of the triple primary tumors were diagnosed by CT or endoscopy[4],[5],[12] with one discovered by PET-CT.[13] Three cases of tumor specimens underwent cancer genetic testing including p53, p16, p21 and cyclinD1, which, however no significant difference were dectected.[6],[12] : A left liver mass (10cmx8cm) with portal vein cancerous embolus and a right colon mass (3cmx3cm) with incomplete colon obstruction The definition of synchronous and metachronous tumors is different in literature. The synchronous tumors were located in the same system (68.42%, 3/19), while the metachronous tumors in different systems (75%, 12/16). Synchronous triple primary tumors has a lower resectability than metachronous (63.16% to 75%) tumors[14]-[16], as synchronous tumors may need a lager range removal of the lesions (Table-I). Only 11 of the reported 37 cases had described the prognosis. The longest survival time of the synchronous patients were 13 months, who was still alive till reported;[7] the longest survival time of the metachronous patients were 18 years.[17]
Table-I

Surgical statistics of synchronous and metachronous primary triple tumors

In one system In different systems Cases of surgery
Synchronous (19 cases)13612/19
Metachronous (16 cases)41212/16

*35 cases in total in the Table-I, 2 of 37 cases were excluded due to non availability of clinical details

The diagnosis and treatment for synchronous triple primary tumors were still challenging. We suggest for elderly male patient of more than 70 years, a comprehensive assessment should be performed if a primary tumor of one system was diagnosed in order to avoid missed diagnosis of synchronous triple primary tumors.
  15 in total

Review 1.  Triple synchronous primary gynecologic carcinomas: a case report and review of the literature.

Authors:  Christopher Stephen Hale; Lili Lee; Khush Mittal
Journal:  Int J Surg Pathol       Date:  2011-06-01       Impact factor: 1.271

2.  [A case of an asynchronic triple tumorous disorder: a rectal adenocarcinoma, a carcinoma of the kidney and a prostatic adenocarcinoma--case report].

Authors:  P Prosvic; M Brod'ák; K Odrázka; P Morávek
Journal:  Rozhl Chir       Date:  2005-01

3.  Metachronous triple cancers of the sigmoid colon, stomach, and esophagus: report of a case.

Authors:  Y Iioka; A Tsuchida; K Okubo; M Ogiso; H Ichimiya; K Saito; Y Osaka; S Sato; T Aoki; Y Koyanagi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

4.  [Triple secondary malignancy of gingiva, palate and esophagus after an allogeneic bone marrow transplantation for cutaneous T-cell lymphoma].

Authors:  Hideyuki Koharazawa; Satoshi Yamaji; Hirotaka Takasaki; Maki Takabayashi; Katsumichi Fujimaki; Jun Taguchi; Heiwa Kanamori; Yoshiaki Ishigatsubo
Journal:  Rinsho Ketsueki       Date:  2005-07

5.  [A case of severe pneumoconiosis with synchronous triple lung cancer].

Authors:  Ryohei Nishino; Haruko Daga; Rumie Sasaki; Chie Moritani; Nobuyuki Ohashi; Ken-ichi Arita; Megumu Fujiwara
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2003-07

6.  Esophageal and laryngeal cancer incidentally found on [18F]fluorodeoxyglucose positron emission tomography/computed tomography during the staging workup for lung cancer.

Authors:  Se Yong Jeon; Se Han Ahn; Cheol Hyeon Kim; Sang Moo Lim; Jae Soo Koh; Jae Cheol Lee
Journal:  Clin Lung Cancer       Date:  2008-07       Impact factor: 4.785

7.  Triple primary cancers of the larynx, lung and thyroid presenting in one patient.

Authors:  F R W Iqbal; A Sani; B S Gendeh; I Aireen
Journal:  Med J Malaysia       Date:  2008-12

8.  Primary jejunal adenocarcinoma as part of multiple primary cancers of the digestive tract.

Authors:  Yutaro Kato; Akira Tsuyuki; Kiyoshi Kikuchi; Yasuo Fujishiro; Minoru Tanabe; Masahiko Watanabe; Soji Ozawa; Masaki Kitajima
Journal:  J Gastroenterol Hepatol       Date:  2008-04       Impact factor: 4.029

9.  [A case report of primary triple cancers in the thyroid, stomach and rectum with evidence of variable oncoprotein expressions].

Authors:  Y Shibutani; D Inoue; H Sugawa; T Mori
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1994-10-20

Review 10.  [Triple cancer in the urinary system: a case report].

Authors:  Yasuhito Funahashi; Osamu Kamihira; Shin Kasugai; Kyosuke Kimura; Akitoshi Fukatsu; Osamu Matsuura
Journal:  Hinyokika Kiyo       Date:  2007-11
View more
  1 in total

1.  Case Report of Synchronous Prostate, Hepatocellular, and Rectal Carcinomas and Review of the Literature.

Authors:  Viktoria Lamprou; Daniel Paramythiotis; Dimitrios Giakoustidis; Anestis Karakatsanis; Athanasios Astreinidis; Moysis Moysidis; Antonios Mihalopoulos; Stefanos Finitsis
Journal:  Case Rep Surg       Date:  2020-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.